Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.



Project LeadsEmail
Chris Price

chris.price.cp1@roche.com

Lori VanMeterlvanmet@ITS.JNJ.com
Katie Warren (PHUSE Project Assistant)

katie@phuse.global.


Objectives & DeliverablesTimelines

Kick off

Q12022Q1 2022

Review current company practices 

Q12022Q1 2022

Develop conference abstract 

Q22022Q2 2022

Draft paper paper

Q32022Q3 2022 

Conference slides 

Q42022Q4 2022

Final paper for public review

Q42022Q4 2022

Final paper published

Q12023Q1 2023


Status
colourBlue
titleCURRENT STATUS

Project approved Q12022Q1 2022



Project MembersOrganisation
Rama EmpatiAstraZeneca
Bess Leroy CDISC
Lisa LinFDA
John Scott FDA
Liping Sun FDA
Steve Wilson FDA
Kim MusgraveAmgen
Cedric DavisterMerck 

Robin White

Eli Lilly and Company

Yongming Qu

Eli Lilly and Company
Santosh K LingalaGilead